IP Library Granted Patent US 12,163,965
Granted Patent B2
US 12,163,965 · App. 17/405,918 · Granted Dec 10, 2024

Methods of culturing and characterizing antibody secreting cells

Inventors: Frances Eun-Hyung Lee (Atlanta, GA); Ignacio Sanz (Atlanta, GA); Doan C. Nguyen (Atlanta, GA)
Assignee: Emory University
G01N33/6854C12N5/163G01N33/5091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,163,965
App. No.
17/405,918
Granted
Dec 10, 2024
Kind
B2
Abstract

This disclosure relates to methods of culturing and characterizing antibody secreting cells. In certain embodiments, this disclosure relates to methods of isolating antibody secreting cells, e.g., long lived plasma cells, replicating the isolated cells in growth media disclosed herein, and determining the nucleic acids sequences in the cells that encode the produced antibodies.

Claims (14)

1. A method of identifying cells that produce antibodies that bind to an antigen comprising

isolating antibody secreting cells from a sample, providing isolated single antibody secreting cells;

mixing the isolated antibody secreting cells with secretions of allogeneic mesenchymal stromal/stem cells and exogenously added A-proliferation-inducing ligand (APRIL) under conditions such that isolated antibody secreting cells replicate providing replicated antibody secreting cells; and

identifying antibodies that specifically bind to the antigen being secreted from the cells indicating the presence of antigen binding antibody secreting cells in the sample.

2. The method of claim 1 wherein mixing the isolated antibody secreting cells with secretions of allogeneic mesenchymal stromal/stem cells and exogenously added A-proliferation-inducing ligand (APRIL) is under hypoxic conditions.

3. The method of claim 1 , wherein the sample is blood, bone marrow, or product derived therefrom.

4. The method of claim 1 , wherein the antibody secreting cells have a cell surface profile of CD19(−), CD38(hi), and CD138(+).

5. The method of claim 1 , wherein the antibody secreting cells have a cell surface profile of CD19+, CD27hi, and CD38hi.

6. The method of claim 1 , wherein the antigen is a vaccine antigen or autoimmune antigen.

7. A method of producing a hybridoma that produces antibodies that bind to an antigen comprising:

isolating antibody secreting cells from a sample providing separated single antibody secreting cells in a plurality of separate areas,

mixing the separated single antibody secreting cells with secretions of allogeneic mesenchymal stromal/stem cells and exogenously added A-proliferation-inducing ligand (APRIL) under conditions such that separated single cells replicate providing replicated homogenous antibody secreting cells; and

identifying homogenous antibody secreting cells that produce antibodies that specifically bind to the antigen; and

fusing a homogenous antibody secreting cell identified to produce antibodies that specifically bind the antigen with an immortalized cell providing hybridoma cells that produce antibodies that specifically bind to the antigen.

Assignments (2)
CONFIRMATORY LICENSE Recorded Dec 6, 2023
From: EMORY UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065778/0359 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2023
From: LEE, FRANCES EUN-HYUNG; SANZ, IGNACIO; NGUYEN, DOAN C.
To: EMORY UNIVERSITY
Reel/Frame 064557/0067 →
Continuity (3)
Division 15992174 · May 30, 2018
Provisional Application 62511468 · May 26, 2017
Related Publication 20210382066A1 · Dec 9, 2021